期刊文献+

盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病变的临床观察 被引量:3

下载PDF
导出
摘要 目的观察盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病变的疗效。方法将56例2型糖尿病并周围神经病变患者随机分为治疗组28例,对照组28例,治疗组予以盐酸丁咯地尔200mg溶于250ml生理盐水中静脉滴注,每日1次;并联合怡开120u口服,每日3次。对照组仅予以盐酸丁咯地尔200mg溶于250ml生理盐水中静脉滴注每日1次。结果入选患者治疗两周后两组神经症状及体征均得到改善,治疗组四肢震动感觉阈值均明显改善,与对照组比有显著差异(P<0.05)。结论盐酸丁咯地尔注射液联合怡开治疗2型糖尿病周围神经病疗效满意,值得临床广泛推广应用。
出处 《江西医药》 CAS 2010年第12期1214-1215,共2页 Jiangxi Medical Journal
  • 相关文献

参考文献3

二级参考文献23

  • 1陶凯忠,第二军医大学学报,2000年,21卷,186页
  • 2Tilton R G,Diabetes,1995年,44卷,234页
  • 3Williamsson J R,Diabetes,1993年,42卷,801页
  • 4Piechota G,Malkiewicz J,Karwat ZD. Diabetes mellitus type 2 as a cause of disability[J]. Przegl Epidemiol,2004,58(4):677-82.
  • 5Gabbay KH. Aldose reductase inhibition in the treatment of diabetic neuropathy:where are we in 2004[J]? Curr Diab Rep,2004,4(6) :405-8.
  • 6Price SA, Agthong S, Middlemas AB, et al. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy:interactions with aldose reductase[J]. Diabetes, 2004,53(7) : 1851-6.
  • 7Coste TC,Gerbi A,Vague P,et al. Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations:natural sources or biotechnological needs[J]? Cell Mol Biol (Noisy-le-grand),2004,50 (7) :845-53.
  • 8Giannini C,Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity[J]. Ann Neurol,1995,37(4) :498-504.
  • 9Ziegler D, Sohr CG, Neurooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy[J]. Diabetes Care,2004,27(9) :2178-83.
  • 10Vincent AM, Russell JW, Low P,et al. Oxidative stress in the pathogenesis of diabetic neuropathy [J ]. Endocr Rev, 2004, 25(4):612-28.

共引文献79

同被引文献36

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部